BioTechGrid – Page 2343

Applied Therapeutics CEO steps down in wake of FDA rejection, warning letter and investor lawsuit

December 20, 2024

A turbulent month at Applied Therapeutics is being capped off with the departure of CEO and chair Shoshana Shendelman, Ph.D.,…

Biotechnology

Sanofi scoops up China rights to Cytokinetics’ heart disease med ahead of approval decision

December 20, 2024

As Cytokinetics’ aficamten awaits approval decisions from regulators in the U.S. and China, Sanofi has picked up China rights to…

Biotechnology

Apollomics, after giving up on GlycoMimetics’ leukemia therapy, posts drug’s latest phase 3 fail

December 20, 2024

The failure of a myeloid leukemia drug in a phase 3 trial in China isn’t a shock to Apollomics, which…

Biotechnology

Novo Nordisk stock crashes after CagriSema misses phase 3 weight-loss goal

December 20, 2024

A phase 3 trial of Novo Nordisk’s next-generation obesity prospect CagriSema has failed to achieve the level of weight loss…

Biotechnology

Idorsia’s sale of Tryvio falls behind schedule, but layoffs remain on track

December 20, 2024

Idorsia’s plans to sell its hypertension drug Tryvio have faced a speedbump, even as the biotech ploughs ahead with around…

Biotechnology

Aadi pulls commercial-to-preclinical pivot, buying ADCs and selling approved drug to reboot business

December 20, 2024

Aadi Bioscience has rebooted its operations, transforming from a commercial business into a preclinical biotech by offloading its approved product and…

Genetics

Mechanism for Cellular RNA’s Role in Antiviral Immune Response Uncovered

December 20, 2024

New research from scientists at the University of Washington (UW) School of Medicine and Duke University describes how cellular RNA…

Genetics

AI Expedites Motor Neuron Analysis and Screening in ALS Research

December 20, 2024

Developing motor neurons from stem cells taken directly from amyotrophic lateral sclerosis (ALS) patients offers new hope for better understanding…

Biotechnology

FDA rejects Zealand Pharma’s GLP-2 analog in rare bowel disease

December 19, 2024

The FDA has denied Zealand Pharma’s approval bid for glepaglutide—a possible challenger to Takeda’s Gattex—in short bowel syndrome (SBS), citing…

Genetics

Flu Vaccine Response Boosted by Coupling Antigens from Multiple Subtypes

December 19, 2024

The seasonal influenza vaccine contains strains of viruses from distinct virus subtypes, but most people who are vaccinated will mount…

Malaria Parasite Membrane Enzymes Emerge as Promising New Drug Targets

Staphylococcal Protein Reprograms Liver Tumor Macrophages to Boost Immunotherapy

Hidden Microbes Inside Mung Bean Show Striking Stress Tolerance and Fungal-Fighting Power

Noisy Gates Put Gate Teleportation to the Test

Prenatal BPA Exposure Rewires the Cerebellum Differently in Male and Female Rat Offspring

Locked and Loaded: Structural Studies Reveal How the SCREW Peptide Engages Its NUT Receptor

Exploring the Future of Healthcare with Panos Karelis

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

Applied Therapeutics CEO steps down in wake of FDA rejection, warning letter and investor lawsuit

Sanofi scoops up China rights to Cytokinetics’ heart disease med ahead of approval decision

Apollomics, after giving up on GlycoMimetics’ leukemia therapy, posts drug’s latest phase 3 fail

Novo Nordisk stock crashes after CagriSema misses phase 3 weight-loss goal

Idorsia’s sale of Tryvio falls behind schedule, but layoffs remain on track

Aadi pulls commercial-to-preclinical pivot, buying ADCs and selling approved drug to reboot business

Mechanism for Cellular RNA’s Role in Antiviral Immune Response Uncovered

AI Expedites Motor Neuron Analysis and Screening in ALS Research

FDA rejects Zealand Pharma’s GLP-2 analog in rare bowel disease

Flu Vaccine Response Boosted by Coupling Antigens from Multiple Subtypes

Siemens Healthineers and Novo team up on fatty liver disease awareness, testing

Cordis’ sirolimus drug-coated balloon earns FDA approval as a breakthrough device

Anaconda Biomed snares $56M in funding for endovascular tech

Medtronic earns FDA clearance for LigaSure use with its Hugo robotic system